Ignite Creation Date:
2025-12-24 @ 2:01 PM
Ignite Modification Date:
2025-12-27 @ 9:10 PM
Study NCT ID:
NCT00876395
Status:
COMPLETED
Last Update Posted:
2018-12-19
First Post:
2009-04-02
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Everolimus in Combination With Trastuzumab and Paclitaxel in the Treatment of HER2 Positive Locally Advanced or Metastatic Breast Cancer
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-09-10
Start Date Type:
ACTUAL
Primary Completion Date:
2014-05-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-10-23
Completion Date Type:
ACTUAL
First Submit Date:
2009-04-02
First Submit QC Date:
None
Study First Post Date:
2009-04-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-10-23
Results First Submit QC Date:
None
Results First Post Date:
2018-12-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-12-18
Last Update Post Date:
2018-12-19
Last Update Post Date Type:
ACTUAL